Section and Research Unit of General Practice, Department of Public Health, University of Copenhagen , Denmark.
Scand J Prim Health Care. 2013 Dec;31(4):235-40. doi: 10.3109/02813432.2013.844410. Epub 2013 Oct 8.
Uncomplicated urinary tract infection (uUTI) is a common reason for antibiotic treatment in primary health care. Due to the increasing prevalence of antibiotic-resistant uropathogens it is crucial to use the most appropriate antibiotics for first-choice empiric treatment of uUTI. Particularly, it is important to avoid antibiotics associated with a high rate of antimicrobial resistance. This study compares national recommendations from six European countries, investigating recommendations for first-choice antibiotic therapy of uUTI.
General practice in six European countries.
Searches were undertaken on PubMed, the Cochrane Library databases, Google, and Google Scholar. Recommendations from different geographical regions in Europe were investigated: Northern Europe (Denmark, Sweden), Western Europe (Scotland), Central Europe (Germany), Southern Europe (Spain), and Eastern Europe (Croatia).
The six countries recommended seven different antibiotics. Five countries recommended more than one antibiotic as first-choice treatment. Half of the countries recommended antibiotics associated with a high rate (> 10-20%) of resistant E. coli. All countries recommended at least one antibiotic associated with a low (< 5%) resistance rate.
The differences in first-choice treatment of uUTI could not be explained by differences in local bacterial aetiology or by different patterns of antimicrobial resistance. Despite resistance rates exceeding 10-20%, sulphamethizole, trimethoprim. or fluoroquinolones were recommended in half of the countries.
Within the European countries there are considerable differences in recommendations for empiric first-choice antibiotic treatment of uUTI. In order to reduce the increasing antimicrobial resistance in Europe, it is important to agree on the most appropriate antibiotics for empiric treatment of uUTI.
单纯性尿路感染(uUTI)是基层医疗保健中抗生素治疗的常见原因。由于抗生素耐药性尿路病原体的患病率不断增加,因此使用最适合的抗生素进行 uUTI 的经验性治疗至关重要。特别是,避免使用与高抗菌药物耐药率相关的抗生素非常重要。本研究比较了来自六个欧洲国家的国家建议,研究了 uUTI 一线治疗的抗生素选择建议。
六个欧洲国家的全科医学。
在 PubMed、Cochrane 图书馆数据库、Google 和 Google Scholar 上进行了检索。研究了来自欧洲不同地理区域的建议:北欧(丹麦、瑞典)、西欧(苏格兰)、中欧(德国)、南欧(西班牙)和东欧(克罗地亚)。
六个国家推荐了七种不同的抗生素。五个国家推荐了一种以上的抗生素作为一线治疗。有一半的国家推荐了与高耐药率(>10-20%)相关的抗生素。所有国家都推荐了至少一种与低耐药率(<5%)相关的抗生素。
uUTI 一线治疗的差异不能用当地细菌病因学的差异或抗菌药物耐药模式的不同来解释。尽管耐药率超过 10-20%,但仍有一半的国家推荐使用磺胺甲噁唑、甲氧苄啶或氟喹诺酮类药物。
在欧洲国家中,对于 uUTI 的经验性一线治疗抗生素的推荐存在相当大的差异。为了减少欧洲抗菌药物耐药性的增加,有必要就 uUTI 的经验性治疗最合适的抗生素达成一致意见。